Gene: ARMH4
Official Full Name: armadillo like helical domain containing 4provided by HGNC
Gene Summary: Predicted to enable TORC2 complex binding activity. Involved in regulation of inflammatory response. Located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24060 | ARMH4 Knockout cell line (HEK293) | Human | ARMH4 | 1:3~1:6 | Negative | Online Inquiry |
KO24061 | ARMH4 Knockout cell line (A549) | Human | ARMH4 | 1:3~1:4 | Negative | Online Inquiry |
ARMH4 Gene Knockout Cell Lines are specifically engineered cellular systems that have undergone targeted gene disruption of the ARMH4 gene. This product is designed to facilitate the investigation of the biological functions and roles of the ARMH4 gene, which has been implicated in numerous cellular pathways, including those related to cancer, stress response, and cell signaling.
These cell lines operate by utilizing advanced CRISPR-Cas9 technology to create precise mutations that render the ARMH4 gene inactive. This approach allows researchers to analyze not only the loss-of-function effects associated with ARMH4 but also provides insights into compensatory mechanisms within the cell, ultimately enhancing our understanding of genetic regulation and cellular homeostasis. Moreover, the knockouts serve as ideal models for drug testing, gene therapy, and the elucidation of complex gene interactions within relevant cellular contexts.
The scientific importance of ARMH4 Gene Knockout Cell Lines lies in their potential applications across various research domains, including cancer biology, pharmacology, and molecular therapeutics. By leveraging these models, researchers can uncover novel therapeutic targets and strategies for diseases where ARMH4 dysregulation is a contributing factor. The precise gene editing intrinsic to these cell lines offers an unparalleled tool for producing data that drives meaningful scientific discovery.
What sets ARMH4 Gene Knockout Cell Lines apart from alternative products is their validated performance and reproducibility, ensured by rigorous quality control measures and characterization against wild-type cell lines. Furthermore, their adaptability to a variety of experimental conditions allows researchers to directly tailor their investigations to fit their specific needs.
For researchers and clinicians focused on gene function and disease mechanisms, these cell lines present remarkable opportunities to advance knowledge in the field and develop innovative therapeutic approaches. Our company has extensive expertise in the development of gene-editing technologies, guaranteeing the highest standards in product quality and customer support for a seamless research experience.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.